Michael Graves's Insider Trades & SAST Disclosures

Michael Graves's most recent trade in Eagle Pharmaceuticals Inc was a trade of 293,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 21, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eagle Pharmaceuticals Inc
Michael Graves Director, Interim Executive Chair & PEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2023 293,000 293,000 - - Employee Stock Option (right to buy)
Eagle Pharmaceuticals Inc
Michael Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 16,253 16,253 - - Stock Option (right to buy)
Eagle Pharmaceuticals Inc
Michael Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2022 11,200 11,200 - - Stock Option (right to buy)
Eagle Pharmaceuticals Inc
Michael Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2021 13,500 13,500 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades